Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease
Clinical trial NCT07141810 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07141810
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-04-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.